title: Trefoil factor expression in biliary epithelium of graft-versus-host disease of the liver after allogeneic hematopoietic cell transplantation.
abstract: BACKGROUND
  The aims of this study were to determine the presence of trefoil factor family-3 (TFF3) expression in biliary epithelial cells (BECs) of chronic graft-versus-host disease (cGVHD) of the liver after allogeneic hematopoietic cell transplantation, to compare such expression in chronic liver diseases (CLD) with/without predominantly biliary disease, and to assess the effect of bile duct injury on the degree of TFF3 expression in BECs of cGVHD.
  
  
  METHODS
  A total of 82 paraffin-embedded liver biopsy samples were reviewed. These samples were basically divided into two distinct groups according to the presence of ductal injury: group 1 with CLD and predominantly biliary disease (n=26: 17 cGVHD and 9 primary biliary cirrhosis [PBC]) and group 2 with CLD and predominantly parenchymal liver disease (n=56: 20 steatohepatitis and 36 chronic viral hepatitis). Group 2 was used as the controls. Immunohistochemistry was performed using a polyclonal anti-TFF3 antibody. Real-time quantitative PCR was used for the detection of TFF3 mRNA expression.
  
  
  RESULTS
  Positive TFF3 immunohistochemical staining and the presence of TFF3 messenger RNA gene expression was demonstrably higher in group 1 than that in group 2 (P<0.0001 and P<0.05, respectively). No significant difference in terms of positive TFF3 stained BECs between GVHD and PBC samples was observed (P>0.05). The extent of TFF3 expression in GVHD samples with severe ductal injury were significantly more common than that of GVHD samples with mild/moderate ductal injury (P<0.0001).
  
  
  CONCLUSIONS
  The expression of TFF3 in cGVHD of the liver is increased in response to bile duct damage and repair. Such expression seems to be related the severity of ductal injury.
authors.affiliation: Department of Gastroenterology, Ankara University School of Medicine, Ankara, Turkey. idilman@dialup.ankara.edu.tr
authors.forename: Ramazan
authors.initials: R
authors.lastname: Idilman
authors.forename: Esra
authors.initials: E
authors.lastname: Erden
authors.forename: Mutlu
authors.initials: M
authors.lastname: Arat
authors.forename: Ender
authors.initials: E
authors.lastname: Soydan
authors.forename: Ozlem
authors.initials: O
authors.lastname: Erkan
authors.forename: Isinsu
authors.initials: I
authors.lastname: Kuzu
authors.forename: Yasemin
authors.initials: Y
authors.lastname: Sahin
authors.forename: Sahin
authors.initials: S
authors.lastname: Coban
authors.forename: Mithat
authors.initials: M
authors.lastname: Bozdayi
authors.forename: Andrew
authors.initials: A
authors.lastname: Giraud
authors.forename: Hamdi
authors.initials: H
authors.lastname: Akan
authors.forename: Selim
authors.initials: S
authors.lastname: Karayalcin
authors.forename: Ali
authors.initials: A
authors.lastname: Ozden
mesh_terms: D000293:Adolescent; D000328:Adult; D001649:Bile Duct Diseases / Q000150:complications / Q000378:metabolism; D001652:Bile Ducts / Q000737:chemistry / Q000378:metabolism* / Q000473:pathology; D002908:Chronic Disease; D004848:Epithelium / Q000378:metabolism / Q000473:pathology; D005260:Female; D006086:Graft vs Host Disease / Q000378:metabolism*; D018380:Hematopoietic Stem Cell Transplantation; D006801:Humans; D007120:Immunochemistry; D008099:Liver / Q000737:chemistry / Q000473:pathology; D008107:Liver Diseases / Q000150:complications / Q000378:metabolism*; D008297:Male; D008875:Middle Aged; D010455:Peptides / Q000032:analysis / Q000235:genetics / Q000378:metabolism*; D012333:RNA, Messenger / Q000032:analysis / Q000378:metabolism; D014184:Transplantation, Homologous; D000071165:Trefoil Factor-3
chemical_list: D010455:Peptides; D012333:RNA, Messenger; C082495:TFF3 protein, human; D000071165:Trefoil Factor-3